Randomized phase II trial of carboplatin combined with weekly paclitaxel (CP) and docetaxel alone (D) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): NJLCG 0801.
Shunichi Sugawara
Honoraria - Sanofi
Makoto Maemondo
Honoraria - Sanofi
Toshiyuki Harada
No relevant relationships to disclose
Akira Inoue
Honoraria - Sanofi
Nobumichi Matsubara
No relevant relationships to disclose
Kana Watanabe
No relevant relationships to disclose
Osamu Ishimoto
No relevant relationships to disclose
Tomohiro Sakakibara
No relevant relationships to disclose
Yuji Minegishi
No relevant relationships to disclose
Kazuhiro Usui
No relevant relationships to disclose
Masahiro Ando
No relevant relationships to disclose
Naoto Morikawa
No relevant relationships to disclose
Yoshiaki Mori
No relevant relationships to disclose
Akihiko Gemma
No relevant relationships to disclose
Toshihiro Nukiwa
No relevant relationships to disclose